Stem cell transplants could be offered to MS patients in new trial
November 30, 2022Research and Development
In a world-first trial, the University of Sheffield and Sheffield Teaching Hospital NHS Foundation Trust will investigate the efficacy of …
Collaboration between BioNTech and Ryvu Therapeutics to develop and commercialise immuno-modulatory small molecule candidates
November 30, 2022Research and Development
Ryvu Therapeutics, a clinical-stage oncology therapeutics development company, has announced a collaboration with BioNTech, which will consist of two parts: …
New Alzheimer’s drug, lecanemab slows disease but divides opinions
November 30, 2022Research and Development
Japanese drugmaker Eisai and its US partner Biogen have announced that their new drug to treat Alzheimer’s disease appeared to …
RadNet’s Aidence AI subsidiary and Google Health enter into agreement to bring lung cancer screening model to market
November 30, 2022Research and Development
Aidence, an AI subsidiary of RadNet which looks at lung health, has partnered with Google Health to license Google Health’s …
Peter Williams
November 29, 2022Business Services
Incyte has announced its appointment of Peter Williams as General Manager for the UK and Ireland division. His new role …
University of Texas and Novartis Pharmaceuticals develop new computer platform for easier drug discovery
November 29, 2022Research and Development
Researchers from both the University of Texas, US and Novartis Pharmaceuticals have developed a computer-based platform which appears to make …
AstraZeneca to acquire Neogene for up to $320m
November 29, 2022Sales and Marketing
AstraZeneca has announced that it is planning to buy Neogene for up to $320m. Biotechnology group Neogene has a focus …
Full-Life Technologies to acquire Focus-X Therapeutics
November 29, 2022Sales and Marketing
Full-Life Technologies, a fully integrated global radiotherapeutics company, has announced that they have agreed to acquire US-based Focus-X Therapeutics.
Siemens Healthineers and Atrium Health team up in $140m deal
November 29, 2022Sales and Marketing
Atrium Health, a US-based non-profit health provider, has signed a partnership with Siemens Healthineers to buy $140m worth of healthcare …
Scott Curley
November 28, 2022Business Services
Following a positive NICE recommendation for VAZKEPA® (icosapent ethyl), which has allowed Amarin to continue with its commercial expansion, Amarin …
Bayer and Orion Corporation-developed prostate cancer treatment approved by NHS England and MHRA
November 28, 2022Medical Communications
NHS England and the Medicines and Healthcare products Regulatory Agency have approved a prostate cancer treatment, developed jointly by Bayar …
Brainomix and Pixyl partner to offer multiple sclerosis treatment
November 28, 2022Medical Communications
In a new partnership, UK-based medical software developer Brainomix will distribute Neuro.MS ‒ French medical imaging company Pixyl’s Software as …
C4X Discovery signs licensing deal worth up to $402m with AstraZeneca
November 28, 2022Sales and Marketing
Pioneering drug discovery company, C4X Discovery Holdings (C4XD) has signed a licensing agreement with AstraZeneca, worth up to $402m. The …
Two-dose chemotherapy drug enters clinical trial for cancer patients
November 28, 2022Research and Development
South Korean biotech firm Hyundai Bioscience’s innovative chemotherapy drug may be able to complete cancer treatments in two doses. The …
NHS nurses strike announced for 15 and 20 December
November 25, 2022Medical Communications
The Royal College of Nursing (RCN) has announced strikes on 15 and 20 December in a continuing pay dispute with …
NICE recommends new life-extending treatment for rare form of gastroesophageal cancer
November 25, 2022Medical Communications
Clinical evidence shows Bristol Myers Squibb’s nivolumab, with chemotherapy, could help extend the lives of patients with untreated HER2-negative, advanced …
The University of Bristol trial to test rapid checks for reduction of antibiotic prescriptions
November 24, 2022Business Services
The University of Bristol has begun a trial to see if the rapid testing of initial symptoms could cut the number …
Iveda reveals AI-driven caregiver assistant, IvedaCare
November 24, 2022Business Services
Iveda, a US-based technology company, has introduced their new cloud-based artificial intelligence (AI) assistant called IvedaCare. The company says they …
Dr Frank Mathias
November 23, 2022Dr Frank Mathias has been appointed as life science firm Oxford Biomedica’s new CEO. Dr Mathias will take on his …
Novo Nordisk suffers profit loss over obesity drug as manufacturing problems continue
November 23, 2022Sales and Marketing
Danish pharma company Novo Nordisk, has reported a 2% loss in their third quarter sales report, compared to the previous …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
